title: MR of the heart under pharmacologic stress.
abstract: Magnetic resonance imaging is one method for assessing cardiac function and perfusion at rest and under stress conditions. In this article, the potential of stress magnetic resonance imaging for evaluating ischemic heart disease is reviewed, and technical aspects of some developments that may contribute to comprehensive magnetic resonance imaging assessment of heart disease under rest and stress are discussed.
authors.affiliation: Department of Radiology, Leiden University Medical Center, The Netherlands.
authors.forename: A
authors.initials: A
authors.lastname: de Roos
authors.forename: R A
authors.initials: RA
authors.lastname: Niezen
authors.forename: H J
authors.initials: HJ
authors.lastname: Lamb
authors.forename: P
authors.initials: P
authors.lastname: Dendale
authors.forename: J H
authors.initials: JH
authors.lastname: Reiber
authors.forename: E E
authors.initials: EE
authors.lastname: van der Wall
mesh_terms: D002316:Cardiotonic Agents / Q000009:adverse effects; D004176:Dipyridamole / Q000009:adverse effects; D004280:Dobutamine / Q000009:adverse effects; D005080:Exercise Test / Q000187:drug effects*; D006801:Humans; D008279:Magnetic Resonance Imaging; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000503:physiopathology*; D014665:Vasodilator Agents / Q000009:adverse effects
chemical_list: D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D004280:Dobutamine; D004176:Dipyridamole